title: Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.
authors.forename: Babu
authors.initials: B
authors.lastname: Makkena
authors.forename: Hani
authors.initials: H
authors.lastname: Salti
authors.forename: Malayannan
authors.initials: M
authors.lastname: Subramaniam
authors.forename: Senthil
authors.initials: S
authors.lastname: Thennapan
authors.forename: Robert H
authors.initials: RH
authors.lastname: Bonow
authors.forename: Frank
authors.initials: F
authors.lastname: Caira
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Spelsberg
authors.forename: Nalini M
authors.initials: NM
authors.lastname: Rajamannan
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000069059:Atorvastatin; D001857:Bone Matrix / Q000378:metabolism*; D002114:Calcinosis / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D002455:Cell Division / Q000187:drug effects; D006349:Heart Valve Diseases / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D006538:Heptanoic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D008943:Mitral Valve; D011758:Pyrroles / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin